Home › Sovrappeso › Florida › Miami
Studi clinici su Sovrappeso a Miami, FL
23 studi su Sovrappeso cercano partecipanti presso sedi a Miami e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
In reclutamentoFase 3
- PharmaDev Clinical Research Institute LLC, Miami
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
In reclutamentoFase 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Age Medical Research Corporation, Miami
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
In reclutamentoFase 1
- Clinical Pharmacology of Miami, Miami
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
In reclutamentoFase 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
In reclutamentoFase 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
In reclutamentoFase 1
- Clinical Pharmacology of Miami, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
In reclutamentoFase 3
- BioMed Research & Medical Center, Miami
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
In reclutamentoFase 3
- Finlay Medical Research, Miami
- Suncoast Research Group LLC, Miami
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
In reclutamentoFase 3
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
In reclutamentoFase 3
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
In reclutamentoFase 2
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
In reclutamentoFase 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Horizon Research Center, Miami
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
In reclutamentoFase 3Volontari sani benvenuti
- ACCOMPLISH-2 Research Site, Miami
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
In reclutamentoFase 3
- PharmaDev Clinical Research Institute LLC, Miami
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
In reclutamentoFase 2
- New Horizon Research Center, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
In reclutamentoFase 3
- Optimus U Corporation, Miami
- Research Institute of South Florida, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
In reclutamentoFase 3
- Optimus U Corporation, Miami
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
In reclutamentoFase 3
- Kailera Clinical Site, Miami
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
In reclutamentoFase 3
- New Horizon Research Center, Miami
- Research Institute of South Florida, Miami
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
In reclutamentoFase 3
- ACCOMPLISH-1 Research Site, Miami
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Studi su Sovrappeso in altre città
- San Antonio, TX34 studi
- Houston, TX33 studi
- Chicago, IL28 studi
- Orlando, FL27 studi
- Las Vegas, NV23 studi
- Atlanta, GA20 studi
- Dallas, TX20 studi
- Washington, DC19 studi
- New York City, NY19 studi
- Jacksonville, FL19 studi
- Austin, TX18 studi
- Havelock, NC17 studi
Altri studi a Miami
- Cancro al seno42 studi
- Cancro (tutti i tipi)36 studi
- Cancro del polmone non a piccole cellule31 studi
- Cancro alla prostata27 studi
- Obesità27 studi
- Leucemia mieloide acuta24 studi
- Cancro ovarico23 studi
- Cancro metastatico23 studi
- Colite ulcerosa22 studi
- Mieloma multiplo21 studi
- Morbo di Alzheimer20 studi
- Cancro ai polmoni20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.